Understanding the Data
RMA of New York reports its success rates annually to both the Society for Assisted Reproductive Technology (SART), a professional organization dedicated to maintaining the integrity of the practice of reproductive medicine in the United States, and the Center for Disease Control and Prevention (CDC). In order to assure that success rate calculations most accurately reflect center experience, SART has specific guidelines to be followed when publicizing success rates. RMA of New York is in full compliance with these guidelines.
The bars above show live birth outcomes for women who initiated an IVF cycle, egg retrieval, and embryo transfer, respectively, between January 1, 2002 and December 31, 2011. Not all patients who begin a cycle undergo an egg retrieval or transfer.
Important note: A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic.
According to SART, what constitutes a pregnancy?
A pregnancy can only be reported after a heartbeat is detected.
Why is 2011 the most recent data available?
Clinics must wait until they receive notification of every single birth from the reporting year before they can submit all data; this means that for 2011, clinics had to wait until at least September of 2012 to compile all live birth data. Once the data is submitted, checked and verified for accuracy, it can then be published on the SART website or CDC website. This process takes several months.
Where can I view RMA of New York's complete success rates report?
You can access the rates by visiting CDC's
website or SART’s